NCT00036894View on ClinicalTrials.gov

CC-5013 in Treating Patients With Recurrent Glioma

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2002

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

lenalidomide

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00036894 - CC-5013 in Treating Patients With Recurrent Glioma | Biotech Hunter | Biotech Hunter